This is the authors' abstract. We don't add key points for this paper.
Many barriers prevent individuals with substance use disorders from receiving hepatitis C virus (HCV) treatment. This study describes 96 patients with active HCV treated in an opioid use disorder bridge clinic model. Of 33 patients who initiated treatment, 25 patients completed treatment, and 13 patients achieved sustained virologic response.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chirunomula et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: